Eric S. Kastango, BS Pharm, MBA, FASHP discusses the 2013 Drug Quality and Security Act, including regulatory changes made and the FDA’s involvement.
On November 27, 2013, President Obama signed the Drug Quality and Security Act (DQSA), legislation that contains important provisions relating to the oversight of compounding of human drugs.
In this webinar, Eric S. Kastango, MBA., BSPharm, FASHP reviews:
- The elements of the changes made to Section 503A of the Federal Food, Drug and Cosmetic Act
- A new section, 503B that deals with outsourcing facilities
- The importance of learning about how FDA is planning to oversee the outsourcing industry
